203 related articles for article (PubMed ID: 21406592)
1. Cellular copper levels determine the phenotype of the Arg875 variant of ATP7B/Wilson disease protein.
Gupta A; Bhattacharjee A; Dmitriev OY; Nokhrin S; Braiterman L; Hubbard AL; Lutsenko S
Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5390-5. PubMed ID: 21406592
[TBL] [Abstract][Full Text] [Related]
2. Molecular events initiating exit of a copper-transporting ATPase ATP7B from the trans-Golgi network.
Hasan NM; Gupta A; Polishchuk E; Yu CH; Polishchuk R; Dmitriev OY; Lutsenko S
J Biol Chem; 2012 Oct; 287(43):36041-50. PubMed ID: 22898812
[TBL] [Abstract][Full Text] [Related]
3. Polarized trafficking and copper transport activity of ATP7B: A mutational approach to establish genotype-phenotype correlation in Wilson disease.
Das S; Mohammed A; Mandal T; Maji S; Verma J; Ruturaj ; Gupta A
Hum Mutat; 2022 Oct; 43(10):1408-1429. PubMed ID: 35762218
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Wilson disease mutations revealed that interactions between different ATP7B mutants modify their properties.
Roy S; McCann CJ; Ralle M; Ray K; Ray J; Lutsenko S; Jayakanthan S
Sci Rep; 2020 Aug; 10(1):13487. PubMed ID: 32778786
[TBL] [Abstract][Full Text] [Related]
5. Apical targeting and Golgi retention signals reside within a 9-amino acid sequence in the copper-ATPase, ATP7B.
Braiterman L; Nyasae L; Guo Y; Bustos R; Lutsenko S; Hubbard A
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G433-44. PubMed ID: 19033537
[TBL] [Abstract][Full Text] [Related]
6. Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B.
Braiterman LT; Murthy A; Jayakanthan S; Nyasae L; Tzeng E; Gromadzka G; Woolf TB; Lutsenko S; Hubbard AL
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):E1364-73. PubMed ID: 24706876
[TBL] [Abstract][Full Text] [Related]
7. Sequence variation in the ATP-binding domain of the Wilson disease transporter, ATP7B, affects copper transport in a yeast model system.
Hsi G; Cullen LM; Macintyre G; Chen MM; Glerum DM; Cox DW
Hum Mutat; 2008 Apr; 29(4):491-501. PubMed ID: 18203200
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin.
van den Berghe PV; Stapelbroek JM; Krieger E; de Bie P; van de Graaf SF; de Groot RE; van Beurden E; Spijker E; Houwen RH; Berger R; Klomp LW
Hepatology; 2009 Dec; 50(6):1783-95. PubMed ID: 19937698
[TBL] [Abstract][Full Text] [Related]
9. Copper binding to the N-terminal metal-binding sites or the CPC motif is not essential for copper-induced trafficking of the human Wilson protein (ATP7B).
Cater MA; La Fontaine S; Mercer JF
Biochem J; 2007 Jan; 401(1):143-53. PubMed ID: 16939419
[TBL] [Abstract][Full Text] [Related]
10. Difference in stability of the N-domain underlies distinct intracellular properties of the E1064A and H1069Q mutants of copper-transporting ATPase ATP7B.
Dmitriev OY; Bhattacharjee A; Nokhrin S; Uhlemann EM; Lutsenko S
J Biol Chem; 2011 May; 286(18):16355-62. PubMed ID: 21398519
[TBL] [Abstract][Full Text] [Related]
11. Hepatic copper-transporting ATPase ATP7B: function and inactivation at the molecular and cellular level.
Bartee MY; Lutsenko S
Biometals; 2007 Jun; 20(3-4):627-37. PubMed ID: 17268820
[TBL] [Abstract][Full Text] [Related]
12. The distinct functional properties of the nucleotide-binding domain of ATP7B, the human copper-transporting ATPase: analysis of the Wilson disease mutations E1064A, H1069Q, R1151H, and C1104F.
Morgan CT; Tsivkovskii R; Kosinsky YA; Efremov RG; Lutsenko S
J Biol Chem; 2004 Aug; 279(35):36363-71. PubMed ID: 15205462
[TBL] [Abstract][Full Text] [Related]
13. Critical roles for the COOH terminus of the Cu-ATPase ATP7B in protein stability, trans-Golgi network retention, copper sensing, and retrograde trafficking.
Braiterman L; Nyasae L; Leves F; Hubbard AL
Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G69-81. PubMed ID: 21454443
[TBL] [Abstract][Full Text] [Related]
14. Polarized sorting of the copper transporter ATP7B in neurons mediated by recognition of a dileucine signal by AP-1.
Jain S; Farías GG; Bonifacino JS
Mol Biol Cell; 2015 Jan; 26(2):218-28. PubMed ID: 25378584
[TBL] [Abstract][Full Text] [Related]
15. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.
de Bie P; van de Sluis B; Burstein E; van de Berghe PV; Muller P; Berger R; Gitlin JD; Wijmenga C; Klomp LW
Gastroenterology; 2007 Oct; 133(4):1316-26. PubMed ID: 17919502
[TBL] [Abstract][Full Text] [Related]
16. Diverse functional properties of Wilson disease ATP7B variants.
Huster D; Kühne A; Bhattacharjee A; Raines L; Jantsch V; Noe J; Schirrmeister W; Sommerer I; Sabri O; Berr F; Mössner J; Stieger B; Caca K; Lutsenko S
Gastroenterology; 2012 Apr; 142(4):947-956.e5. PubMed ID: 22240481
[TBL] [Abstract][Full Text] [Related]
17. DKWSLLL, a versatile DXXXLL-type signal with distinct roles in the Cu(+)-regulated trafficking of ATP7B.
Lalioti V; Hernandez-Tiedra S; Sandoval IV
Traffic; 2014 Aug; 15(8):839-60. PubMed ID: 24831241
[TBL] [Abstract][Full Text] [Related]
18. A structural model of the copper ATPase ATP7B to facilitate analysis of Wilson disease-causing mutations and studies of the transport mechanism.
Schushan M; Bhattacharjee A; Ben-Tal N; Lutsenko S
Metallomics; 2012 Jul; 4(7):669-78. PubMed ID: 22692182
[TBL] [Abstract][Full Text] [Related]
19. The loop connecting metal-binding domains 3 and 4 of ATP7B is a target of a kinase-mediated phosphorylation.
Bartee MY; Ralle M; Lutsenko S
Biochemistry; 2009 Jun; 48(24):5573-81. PubMed ID: 19405516
[TBL] [Abstract][Full Text] [Related]
20. The role of metal binding and phosphorylation domains in the regulation of cisplatin-induced trafficking of ATP7B.
Safaei R; Adams PL; Mathews RA; Manorek G; Howell SB
Metallomics; 2013 Aug; 5(8):964-72. PubMed ID: 23803742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]